The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05727904
Brief Title: Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

First Submitted : February 6, 2023
First Submitted that Met QC Criteria : February 6, 2023
First Posted : February 14, 2023

Last Update Submitted that Met QC Criteria : May 13, 2024
Last Update Posted : May 16, 2024